Biocon Market Cap

Biocon has a market cap or net worth of 586.25 billion as of April 29, 2026. Its market cap has increased by 59.30% in one year.

Market Cap

586.25B

Enterprise Value

753.09B

Revenue

168.27B

Ranking

n/a

PE Ratio

76.09

Stock Price

362.25

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 586.25B, an increase of 1,190.94%. That is a compound annual growth rate of 12.29%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	586.25B	11.53%
Dec 31, 2025	525.64B	20.22%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anthem Biosciences	434.85B
OneSource Specialty Pharma	202.11B
Concord Biotech	112.15B
Blue Jet Healthcare	76.92B
Supriya Lifescience	56.72B
Zota Health Care	44.32B
Dishman Carbogen Amcis	28.87B
Panacea Biotec	23.09B

Market Cap Rankings